Kangrun Bio
Latest round
- Series C
Last raised
- Jul 2025
Total raised
- Undisclosed
Investors
- 6
About Kangrun Bio
Founded in 2011 and based in Changzhou, China, Kangrun Bio is a vaccine company integrating R&D, production, and sales. The company boasts comprehensive hardware facilities, including an independent viral vaccine production workshop, R&D laboratory, quality control laboratory, and animal experiment center. Kangrun Bio specializes in the development and production of innovative vaccines, including a lyophilized rabies vaccine utilizing Vero cell technology, a quadrivalent influenza virus split vaccine, and several multivalent hand-foot-and-mouth disease vaccines. The company is also advancing several recombinant protein and mRNA vaccines targeting a range of infectious diseases, serving healthcare providers, hospitals, and clinics primarily in China, with plans for expansion into Southeast Asia. Kangrun Bio generates revenue through direct sales of its vaccines to healthcare institutions and distributors, focusing on bulk sales to hospitals and clinics. Revenue is derived from commercial sales and partnerships with governmental health organizations facilitating vaccination programs.
Who invested in Kangrun Bio
6 investors across 1 round
See all investors in Kangrun Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Jul 6, 2025
Amount
Undisclosed
Investors
Questions about Kangrun Bio
Who invested in Kangrun Bio?
Kangrun Bio has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kangrun Bio raised?
Kangrun Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Kangrun Bio last raise money?
Kangrun Bio's most recent round on record is a Series C, in Jul 2025.
What does Kangrun Bio do?
Founded in 2011 and based in Changzhou, China, Kangrun Bio is a vaccine company integrating R&D, production, and sales.
Where is Kangrun Bio headquartered?
Kangrun Bio is headquartered in Changzhou, China.
Which VCs invest in companies like Kangrun Bio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Kangrun Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Kangrun Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.